Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD)

被引：0

作者：

Montero-Vallejo, Rocio ^{[1
,2
,3
]}

Gallego-Duran, Rocio ^{[1
,2
,3
]}

Maya, Douglas ^{[1
,2
,3
]}

Gato Zambrano, Sheila ^{[1
,2
,3
]}

Garcia Fernandez, Vanessa ^{[1
,2
,3
]}

Munoz Hernandez, Rocio ^{[1
,2
,3
]}

Gil-Gomez, Antonio ^{[1
,2
,3
]}

Alvarez-Ossorio, Angela Rojas ^{[1
,2
,3
]}

Fernandez-Barrena, Maite G. ^{[4
]}

Maria Herranz, Jose ^{[4
]}

Hernandez-Gea, Virginia ^{[5
]}

Camprecios, Genis ^{[5
]}

Anton, Aina ^{[5
]}

del Carmen Rico, Maria ^{[1
,2
,3
]}

Martin-Bermudo, Franz ^{[6
]}

Romero Gomez, Manuel ^{[1
,2
,3
]}

Ampuero, Javier ^{[1
,2
,3
]}

机构：

[1] Hosp Univ Virgen Rocio, Serv Aparato Digest, Seville, Spain

[2] Univ Seville, Inst Biomed Sevilla HUVR CSIC US, SeLiver Grp, Seville, Spain

[3] CIBEREHD Sevilla, Seville, Spain

[4] Univ Navarra, Programa Hepatol, CIMA, CIBEREHD, Pamplona, Spain

[5] Univ Barcelona, Hosp Clin, Unidad Hemodinam Hepat, IDIBAPS,Serv Hepatol,CIBEREHD, Barcelona, Spain

[6] Ctr Andaluz Biol Mol Med Regenerat CABIMER, Seville, Spain

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-457

引用

页码：S770 / S772

页数：3

共 50 条

[1] Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review
Nasiri-Ansari, Narjes
Androutsakos, Theodoros
Flessa, Christina-Maria
Kyrou, Ioannis
Siasos, Gerasimos
Randeva, Harpal S.
Kassi, Eva
Papavassiliou, Athanasios G.
CELLS, 2022, 11 (16)
[2] ARE BIOMARKERS FOR CARDIOVASCULAR DISEASE INCREASED IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)?
Elsheikh, Elzafir
Tran, Henry A.
Paik, James
Felix, Sean C.
Jeffers, Thomas
Younoszai, Zahra
Locklear, Cameron T.
Allawi, Hussain
Fang, Yun
Arsalla, Aimal
Noor, Bashir
Kalachi, Kourosh
Racila, Andrei
Lam, Brian P.
Goodman, Zachary
Gerber, Lynn
Younossi, Zobair M.
GASTROENTEROLOGY, 2018, 154 (06) : S950 - S950
[3] HIGH SERUM ENDOCAN IS A MARKER OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CORONARY ARTERY DISEASE (CAD)
Elsheikh, E.
Younoszai, Z.
Otgonsuren, M.
Hunt, S.
Raybuck, B.
Younossi, Z. M.
JOURNAL OF HEPATOLOGY, 2013, 58 : S529 - S530
[4] ENDOTHELIAL DYSFUNCTION IN PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE
Pacifico, L.
Martino, F.
Cantisani, V.
Poggiogalle, E.
Anania, C.
Olivero, G.
Verdecchia, P.
Ferraro, F.
Chiesa, C.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E48 - E48
[5] Nonalcoholic Fatty Liver disease (NAFLD)
Zeuzem, S.
Trautwein, C.
GASTROENTEROLOGE, 2020, 15 (02): : 77 - 77
[6] Nonalcoholic Fatty Liver Disease and Endothelial Dysfunction in Patients With Type 2 Diabetes
Shin, Jang Yel
Lim, Jung Soo
Lee, Mi Young
Chung, Choon Hee
DIABETES, 2013, 62 : A119 - A119
[7] In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction
Minville, Caroline
Hilleret, Marie-Noelle
Tamisier, Renaud
Levy, Patrick
Zarski, Jean-Pierre
Pepin, Jean-Louis
EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[8] In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction
Minville, C.
Hilleret, M. N.
Tamisier, R.
Levy, P.
Zarski, J. P.
Pepin, J. L.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 29 - 29
[9] Role of cytokines in patients with nonalcoholic fatty liver disease (NAFLD)
Duseja, A.
Kumar, A.
Thumburu, K. K.
Das, A.
Dhiman, R. K.
Chawla, Y. K.
Kohli, K. K.
Bhansali, A.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A65 - A65
[10] Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD)
Yoneda, Mosato
Mawatori, Hironori
Higurashi, Takurno
Iida, Hiroshi
Nozaki, Yuichi
Endo, Hiroki
Fujita, Koji
Kirikoshi, Hiroyuki
Tamano, Masoya
Yoneda, Masashi
Hiroishi, Hideyuki
Kubota, Kensuke
Saito, Sotoru
Nakojima, Atsushi
HEPATOLOGY, 2007, 46 (04) : 319A - 319A

← 1 2 3 4 5 →